Title : IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment.

Pub. Date : 2021 Jul

PMID : 34095989






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 IDH mutations induce a neomorphic enzyme that converts alpha-ketoglutarate to the oncometabolite D-2-hydroxyglutarate, which leads to widespread effects on cellular epigenetics and metabolism. alpha-hydroxyglutarate isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens
2 Targeting D-2-hydroxyglutarate is considered a novel attractive therapeutic approach for low-grade gliomas and the insights from clinical trials suggest that mutant-selective IDH inhibitors are the ideal candidates, with a favorable benefit/risk ratio. alpha-hydroxyglutarate isocitrate dehydrogenase (NADP(+)) 1 Homo sapiens